+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vitro Diagnostic Products Market by Product Type (Instruments, Reagents, Services), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User, Test Mode - Global Forecast 2025-2030- Product Image
In Vitro Diagnostic Products Market by Product Type (Instruments, Reagents, Services), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User, Test Mode - Global Forecast 2025-2030- Product Image
New

In Vitro Diagnostic Products Market by Product Type (Instruments, Reagents, Services), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User, Test Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133222
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In Vitro Diagnostic Products Executive Summary Uncovering Core Market Fundamentals Strategic Imperatives and Foundational Insights for Industry Decision Makers

The in vitro diagnostic products sector stands at a pivotal juncture where technological breakthroughs, regulatory evolution, and shifting healthcare demands converge to shape its trajectory. As global healthcare stakeholders prioritize precision medicine and early disease detection, in vitro diagnostics have become a cornerstone of clinical decision-making, delivering critical insights across diverse medical fields. This rising importance underscores the need for a consolidated view of market fundamentals, enabling decision makers to align investments with emergent opportunities and mitigate potential risks.

This executive summary offers an authoritative foundation by unpacking core market drivers, examining disruptive trends, and highlighting vital strategic imperatives. By synthesizing qualitative and quantitative evidence, this overview bridges the gap between high-level vision and actionable understanding, equipping industry participants-from device manufacturers and reagent suppliers to software innovators and service providers-with the intelligence required to navigate complex ecosystems. In doing so, it establishes the context for subsequent analysis in areas such as regulatory shifts, tariff impacts, segmentation insights, and regional dynamics.

Navigating the Transformative Shifts Disrupting Innovation Adoption Regulatory Dynamics and Competitive Positioning in the In Vitro Diagnostics Arena

Recent years have witnessed transformational shifts within the in vitro diagnostics landscape, driven by advances in molecular technologies, the integration of digital health modalities, and evolving reimbursement frameworks. Molecular assays leveraging next generation sequencing and isothermal amplification are redefining detection thresholds, expanding the scope of early-stage disease screening and personalized therapeutics. Concurrently, the convergence of artificial intelligence and cloud-based data management is empowering laboratories with real-time analytics, predictive maintenance, and streamlined workflows.

Complementing these innovation vectors, regulatory agencies are adapting to faster approval pathways and harmonized standards, facilitating accelerated market access while maintaining stringent quality benchmarks. This regulatory momentum is complemented by strategic partnerships among diagnostics players, academic institutions, and healthcare networks, fostering collaborative R&D and shared infrastructure. As a result, the industry is witnessing a pronounced shift from standalone instruments to integrated diagnostic ecosystems, where seamless interoperability and end-to-end solutions become decisive competitive differentiators.

Assessing the Cumulative Impact of 2025 United States Tariff Adjustments on Supply Chains Cost Structures and Global Trade Dynamics in Diagnostics

The imposition of new United States tariffs effective in 2025 has precipitated a ripple effect across in vitro diagnostic supply chains, compelling stakeholders to reassess sourcing strategies and cost allocations. Components critical to automated analyzers, PCR systems, and sequencing platforms-many of which originate from tariff-impacted regions-now carry elevated landed costs, prompting manufacturers to explore alternative procurement avenues and localized assembly models.

These tariff adjustments have also influenced reagent pricing, particularly within molecular diagnostics and immunoassay segments, where specialized raw materials and proprietary enzymes are subject to cross-border levies. In response, some organizations have accelerated partnerships with domestic suppliers or established in-country manufacturing to mitigate exposure. Over time, this strategic pivot may reshape global trade patterns, as companies balance short-term cost pressures with the long-term benefits of supply chain resilience and regional manufacturing hubs.

Revealing Key Segmentation Insights across Product Types Technologies Applications End Users and Test Modes Driving In Vitro Diagnostic Ecosystems

A granular evaluation of in vitro diagnostic market segmentation reveals drivers that extend from core instrumentation to test mode preferences across varied clinical settings. Within product categories, instruments encompassing automated analyzers, PCR systems, point of care instruments, and sequencing systems demonstrate distinct innovation cycles, while reagent subcategories such as clinical chemistry, hematology, immunoassay, microbiology, and molecular diagnostics each present unique formulation and regulatory complexities. Services spanning laboratory operations and technical support further differentiate vendor value propositions, as service excellence becomes an integral differentiator. Complementary software solutions dedicated to data management and diagnostic imaging are enhancing workflow efficiency and enabling advanced analytics.

When viewed through the lens of technology, molecular diagnostics continues to outpace traditional methodologies. Isothermal amplification, next generation sequencing, and both real time and digital PCR modalities are driving specificity and throughput gains. Culture based microbiology systems and MALDI-TOF platforms remain indispensable for bacterial identification, whereas chemiluminescence, ELISA, and fluorescence immunoassay formats lead in high-volume biomarker screening. Clinical chemistry instruments now bifurcate between centralized automated platforms and decentralized point of care chemistry analyzers, while hematology analyzers leverage automated counts and flow cytometry for detailed cellular profiling.

Application areas from cardiology and diabetes management to infectious diseases and oncology reflect evolving clinical priorities. Bacterial, parasitic, and viral infectious disease tests are being refined for rapid turnaround and multiplex capability, whereas hematological malignancy and solid tumor diagnostic workflows increasingly integrate genomic and proteomic assays. End users span academic and research institutes, clinical laboratories, hospitals, point of care settings, and dedicated research laboratories, each demanding tailored solutions aligned to operational scale and regulatory requirements. Finally, test mode preferences are delineated across central laboratory testing, near patient testing, and point of care testing environments, with each mode influencing instrument design, reagent packaging, and data connectivity features.

Analyzing Regional Dynamics across Americas Europe Middle East Africa and Asia Pacific Highlighting Growth Drivers Challenges and Market Trajectories

Regional analysis underscores distinct growth patterns and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, well-established healthcare infrastructure and favorable reimbursement policies support high adoption rates of advanced molecular and immunoassay platforms. However, the region also grapples with cost containment pressures, prompting stakeholders to emphasize operational efficiency and value-based procurement models.

Within Europe, Middle East & Africa, regulatory harmonization efforts alongside diverse healthcare delivery frameworks create a mosaic of market access pathways. West European countries often lead in early adoption of cutting-edge diagnostics, while emerging markets in EMEA present untapped potential, driven by rising healthcare expenditure and expanding laboratory networks. Meanwhile, Asia-Pacific exhibits robust investment in local manufacturing and R&D, bolstered by government initiatives promoting biotechnology innovation. Rapidly aging populations in key markets are enhancing demand for diabetes, cardiovascular, and oncology diagnostics, while telehealth integration continues to accelerate remote and point of care testing deployment.

Examining Key Company Profiles and Competitive Intelligence to Illuminate Strategic Partnerships Innovation Pipelines and Market Positioning in Diagnostics

Leading organizations in the in vitro diagnostics domain are distinguished by their multifaceted strategies encompassing product innovation, strategic alliances, and global footprint expansion. Top-tier diagnostics manufacturers are channeling resources into next generation sequencing workflows, digital PCR platforms, and point of care systems designed for decentralized testing environments. Strategic collaborations with biotechnology firms and academic centers are broadening assay portfolios and accelerating time-to-market for niche applications.

In parallel, software and data management providers are forging partnerships with instrument vendors and clinical networks to deliver integrated solutions that streamline laboratory operations. Companies offering end-to-end services, from installation to technical support, are reinforcing customer loyalty by embedding predictive maintenance and performance analytics into support agreements. As competition intensifies, mergers and acquisitions have emerged as a key growth lever, enabling companies to rapidly scale geographic presence, augment technology stacks, and diversify product pipelines across core diagnostic segments.

Formulating Actionable Strategic Recommendations to Enhance Operational Agility Innovation Capacity and Market Resilience for Industry Stakeholders

Industry leaders should prioritize a combination of innovation investment, supply chain resilience, and strategic collaborations to navigate the evolving in vitro diagnostics ecosystem. By allocating resources toward modular, customizable platforms, organizations can respond swiftly to emergent clinical needs and regulatory changes. Establishing or expanding regional manufacturing and assembly operations will mitigate tariff exposure while enhancing responsiveness to local market demands.

Simultaneously, fostering alliances with software developers and digital health enterprises will unlock new data-driven service models, elevating customer engagement and enabling predictive laboratory management. Companies should also refine value-based pricing frameworks and outcome-oriented partnerships with payers and healthcare providers to reinforce the value proposition of advanced diagnostics. Continuous monitoring of regulatory updates, coupled with proactive compliance strategies, will be essential for expediting market entry and sustaining competitive advantage.

Detailing Research Methodology Employed for Comprehensive Data Collection Analysis Validation and Strategic Interpretation in In Vitro Diagnostics Research

This research integrates primary and secondary methodologies to ensure robust, balanced insights into the in vitro diagnostic market. Primary research comprised in-depth interviews with industry executives, laboratory directors, and key opinion leaders to validate emerging trends, technology adoption drivers, and regional market nuances. Simultaneously, proprietary surveys captured operational metrics, purchasing criteria, and future investment intentions across instrument, reagent, software, and service segments.

Secondary research drew upon peer-reviewed journals, regulatory agency publications, and corporate disclosures to construct a comprehensive dataset. Data triangulation techniques reconciled divergent sources, while analytical frameworks assessed the impact of technological innovations, tariff adjustments, and regional policy shifts. Rigorous validation processes ensured the integrity and relevance of insights, with iterative review cycles conducted by subject matter experts. This methodological rigor underpins the strategic intelligence presented throughout this report.

Concluding Perspectives Synthesize Strategic Imperatives Industry Trends and Future Outlook for In Vitro Diagnostics Development and Market Evolution

In summation, the in vitro diagnostic products landscape is characterized by rapid technological convergence, shifting regulatory paradigms, and evolving market structures. Stakeholders must navigate tariff-induced supply chain realignments, capitalize on segmentation-driven growth pockets, and tailor regional strategies to local healthcare ecosystems. Companies that integrate modular innovation pathways, leverage digital connectivity, and pursue strategic alliances will be best positioned to harness emerging opportunities.

As the sector advances, a balanced approach that marries operational resilience with forward-looking investments will enable sustainable growth. By adhering to the strategic imperatives articulated herein, industry participants can steer their organizations toward leadership in diagnostic excellence, ensuring that critical insights continue to empower clinical decision-making and improve patient outcomes globally.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Automated Analyzers
      • PCR Systems
      • Point Of Care Instruments
      • Sequencing Systems
    • Reagents
      • Clinical Chemistry
      • Hematology
      • Immunoassay
      • Microbiology
      • Molecular Diagnostics
    • Services
      • Laboratory Services
      • Technical Support
    • Software
      • Data Management
      • Diagnostic Imaging
  • Technology
    • Clinical Chemistry
      • Automated Chemistry
      • Point Of Care Chemistry
    • Hematology
      • Automated Hematology
      • Flow Cytometry
    • Immunoassay
      • Chemiluminescence
      • ELISA
      • Fluorescence Immunoassay
    • Microbiology
      • Culture Based
      • MALDI TOF
    • Molecular Diagnostics
      • Isothermal Amplification
      • Next Generation Sequencing
      • PCR
        • Digital PCR
        • Real Time PCR
  • Application
    • Cardiology
    • Diabetes
    • Infectious Diseases
      • Bacterial
      • Parasitic
      • Viral
    • Oncology
      • Hematological Malignancies
      • Solid Tumors
  • End User
    • Academic And Research Institutes
    • Clinical Laboratories
    • Hospitals
    • Point Of Care Settings
    • Research Laboratories
  • Test Mode
    • Central Laboratory Testing
    • Near Patient Testing
    • Point Of Care Testing
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms into in vitro diagnostic platforms for predictive analytics
5.2. Development of multiplexed point of care molecular assays enabling simultaneous pathogen detection in minutes
5.3. Adoption of microfluidic lab on a chip technologies for rapid high throughput sample processing in clinical labs
5.4. Expansion of next generation sequencing based liquid biopsy tests for early cancer detection and treatment monitoring
5.5. Growth of digital pathology solutions combining whole slide imaging with cloud based diagnostic workflows and AI driven analysis
5.6. Emergence of cost effective CRISPR based diagnostic kits for rapid infectious disease screening in decentralized settings
5.7. Increasing regulatory approvals for companion diagnostic assays linked to targeted oncology therapies across global markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. In Vitro Diagnostic Products Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Automated Analyzers
8.2.2. PCR Systems
8.2.3. Point Of Care Instruments
8.2.4. Sequencing Systems
8.3. Reagents
8.3.1. Clinical Chemistry
8.3.2. Hematology
8.3.3. Immunoassay
8.3.4. Microbiology
8.3.5. Molecular Diagnostics
8.4. Services
8.4.1. Laboratory Services
8.4.2. Technical Support
8.5. Software
8.5.1. Data Management
8.5.2. Diagnostic Imaging
9. In Vitro Diagnostic Products Market, by Technology
9.1. Introduction
9.2. Clinical Chemistry
9.2.1. Automated Chemistry
9.2.2. Point Of Care Chemistry
9.3. Hematology
9.3.1. Automated Hematology
9.3.2. Flow Cytometry
9.4. Immunoassay
9.4.1. Chemiluminescence
9.4.2. ELISA
9.4.3. Fluorescence Immunoassay
9.5. Microbiology
9.5.1. Culture Based
9.5.2. MALDI TOF
9.6. Molecular Diagnostics
9.6.1. Isothermal Amplification
9.6.2. Next Generation Sequencing
9.6.3. PCR
9.6.3.1. Digital PCR
9.6.3.2. Real Time PCR
10. In Vitro Diagnostic Products Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Diabetes
10.4. Infectious Diseases
10.4.1. Bacterial
10.4.2. Parasitic
10.4.3. Viral
10.5. Oncology
10.5.1. Hematological Malignancies
10.5.2. Solid Tumors
11. In Vitro Diagnostic Products Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Clinical Laboratories
11.4. Hospitals
11.5. Point Of Care Settings
11.6. Research Laboratories
12. In Vitro Diagnostic Products Market, by Test Mode
12.1. Introduction
12.2. Central Laboratory Testing
12.3. Near Patient Testing
12.4. Point Of Care Testing
13. Americas In Vitro Diagnostic Products Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa In Vitro Diagnostic Products Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific In Vitro Diagnostic Products Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. bioMérieux SA
16.3.7. Becton, Dickinson and Company
16.3.8. QIAGEN N.V.
16.3.9. Sysmex Corporation
16.3.10. Bio-Rad Laboratories, Inc.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. IN VITRO DIAGNOSTIC PRODUCTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IN VITRO DIAGNOSTIC PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IN VITRO DIAGNOSTIC PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHAI
FIGURE 26. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHSTATISTICS
FIGURE 27. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHCONTACTS
FIGURE 28. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IN VITRO DIAGNOSTIC PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNICAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNICAL SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MALDI TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PARASITIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEAR PATIENT TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEAR PATIENT TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 221. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 224. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 225. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 226. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 227. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 228. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 229. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 230. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 231. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 234. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 235. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 236. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 237. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 238. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 239. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 240. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 241. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 242. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 243. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 244. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 245. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 248. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 249. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 254. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 270. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 271. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 272. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 273. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 274. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 275. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 278. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 279. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 282. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 283. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 284. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 285. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL IN VITRO DIAGNOST

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this In Vitro Diagnostic Products Market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.

Related Topics

Related Reports

In-Vitro Diagnostics Quality Control Market by Product Type (Analyzers & Instruments, Control Materials, QC Reagents), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Quality Control Market by Product Type (Analyzers & Instruments, Control Materials, QC Reagents), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
In-Vitro Diagnostics Instrument Market by Instrument Type (Chemistry Analyzer, Coagulation Analyzer, Hematology Analyzer), Application (Autoimmune, Cardiac Markers, Diabetes), Technology, End User, Configuration - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Instrument Market by Instrument Type (Chemistry Analyzer, Coagulation Analyzer, Hematology Analyzer), Application (Autoimmune, Cardiac Markers, Diabetes), Technology, End User, Configuration - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Canada in Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Services), Technique, Application, End-use, Test Location, Province with Growth Forecasts, 2025-2030 - Product Image

Canada in Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Services), Technique, Application, End-use, Test Location, Province with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Canada
From
Latex Particle for In-Vitro Diagnostics Market by Distribution Channel (Direct Sales, Distributors), Product Type (Instruments, Reagents And Consumables, Software And Services), End User, Technology, Application - Global Forecast 2025-2030 - Product Image

Latex Particle for In-Vitro Diagnostics Market by Distribution Channel (Direct Sales, Distributors), Product Type (Instruments, Reagents And Consumables, Software And Services), End User, Technology, Application - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End Use (Hospitals, Laboratory), Application, Technology (Molecular Diagnostics), and Region with Growth Forecasts, 2025-2030 - Product Image

In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End Use (Hospitals, Laboratory), Application, Technology (Molecular Diagnostics), and Region with Growth Forecasts, 2025-2030

  • Report
  • 320 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.